These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 29053044

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy.
    Erdei A, Steiber Z, Molnar C, Berenyi E, Nagy EV.
    BMC Ophthalmol; 2018 Jan 12; 18(1):5. PubMed ID: 29329570
    [Abstract] [Full Text] [Related]

  • 4. Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease.
    Monteiro ML, Moritz RB, Angotti Neto H, Benabou JE.
    Clinics (Sao Paulo); 2011 Jan 12; 66(8):1329-34. PubMed ID: 21915479
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemotherapy-induced exacerbations of thyroid orbitopathy in a patient with B-cell lymphoma.
    Liu C, Dalm VASH, van Hagen PM, Croon-de Boer F, Paridaens D.
    Orbit; 2018 Aug 12; 37(4):299-302. PubMed ID: 29300515
    [Abstract] [Full Text] [Related]

  • 8. Superior ophthalmic vein thrombosis as an initial manifestation of antiphospholipid syndrome.
    Dey M, Charles Bates A, McMillan P.
    Orbit; 2013 Feb 12; 32(1):42-4. PubMed ID: 23387454
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Optimization of the treatment of moderate to severe and active thyroid orbitopathy considering the recommendations of the European Group on Graves' Orbitopathy (EUGOGO) [Optymalizacja leczenia umiarkowanej do ciężkiej i aktywnej orbitopatii tarczycowej z uwzględnieniem zaleceń European Group on Graves' Orbitopathy (EUGOGO)].
    Nowak M, Marek B, Kos-Kudła B, Siemińska L, Londzin-Olesik M, Głogowska-Szeląg J, Nowak W, Kajdaniuk D.
    Endokrynol Pol; 2022 Feb 12; 73(4):756-777. PubMed ID: 36059167
    [Abstract] [Full Text] [Related]

  • 11. Natural history of graves' orbitopathy after treatment.
    Menconi F, Leo M, Sabini E, Mautone T, Nardi M, Sainato A, Sellari-Franceschini S, Vitti P, Marcocci C, Marinò M.
    Endocrine; 2017 Aug 12; 57(2):226-233. PubMed ID: 27709471
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features.
    Konuk O, Onaran Z, Ozhan Oktar S, Yucel C, Unal M.
    Graefes Arch Clin Exp Ophthalmol; 2009 Nov 12; 247(11):1555-9. PubMed ID: 19609549
    [Abstract] [Full Text] [Related]

  • 15. Orbital diseases mimicking graves' orbitopathy: a long-standing challenge in differential diagnosis.
    Marinò M, Ionni I, Lanzolla G, Sframeli A, Latrofa F, Rocchi R, Marcocci C.
    J Endocrinol Invest; 2020 Apr 12; 43(4):401-411. PubMed ID: 31691261
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
    Nowak M, Siemińska L, Karpe J, Marek B, Kos-Kudła B, Kajdaniuk D.
    J Endocrinol Invest; 2016 Jan 12; 39(1):63-72. PubMed ID: 26062519
    [Abstract] [Full Text] [Related]

  • 18. Isolated primary amyloidosis of the inferior rectus muscle mimicking Graves' orbitopathy.
    Monteiro ML, Gonçalves AC, Bezerra AM.
    Einstein (Sao Paulo); 2016 Jan 12; 14(4):553-556. PubMed ID: 28076605
    [Abstract] [Full Text] [Related]

  • 19. Thyroid orbitopathy masked a carotid-cavernous fistula. Case report.
    Urdapilleta-Contreras M, Padilla-Pérez L, Aguilar-Ruiz A, Verdugo-Unigarro A.
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Aug 12; 94(8):400-404. PubMed ID: 31176495
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.